Furthermore, HBOT clears senescent cells, improves T cell function exhaustion, and enhances the proliferative capacity of CD8+T cells by 2.5 times in tumor-infiltrating lymphocyte (TIL) therapy (39). Here, CD8A is linked to neoplasm.